Saturday 17 October 2026
Export HYPD’s income statement to Excel — free account
Hyperion DeFi, Inc.
HYPD Healthcare Biotechnology
Hyperion DeFi, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $813,500.00, up 1,319.7% from fiscal 2024. In the quarter to June 2026, revenue grew 2,333.3%, EPS grew 140.4%, free cash flow grew 86.8% and total debt rose 12.3%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
2.84
0.31
−9.84%
Follow HYPD
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
5 | 5 | 5 | — |
| (70.89%) | (336.14%) | (165.15%) | (24.63%) | ||
| (50.00%) | (169.57%) | (105.93%) | (20.32%) | ||
ROIC |
(23.51%) | (68.63%) | (37.62%) | 2.73% | |
Return on Tangible Assets |
(522.82%) | (1,034.13%) | (930.07%) | (231.78%) | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(13.68) | (2.95) | (1.37) | (5.44) | |
Free Cash Flow |
(82.46) | (14.77) | (14.52) | (77.17) | |
Capital Expenditures |
(65.64) | — | — | (63.19) | |
| Other line items | |||||
Cash ROIC |
(95.18%) | (26.77%) | (19.94%) | (64.30%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.00 | 3.11 | 0.00 | 0.00 | |
Inventory Turnover |
— | 0.00 | — | — | |
Average Days of Payables |
0.00 | 32.81 | 0.00 | 0.00 | |
Days of Inventory on Hand |
— | 0.00 | — | — | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
1,061.83% | 227.04% | 144.11% | 64.84% | |
Selling, General and Administrative Expense of Revenue |
4,569.93% | 2,041.07% | 1,824.42% | 1,109.22% | |
Share Based Compensation of Revenue |
1,375.12% | 757.22% | 746.61% | 275.26% | |
Interest Coverage |
(14.18) | (29.99) | (29.08) | 4.85 | |
Operating CF/Net income |
0.64 | 0.31 | 0.36 | 0.81 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
(57.31) | 0.00 | 0.00 | (129.31) | |
Revenue per Share |
0.06 | 0.17 | 0.10 | 0.10 | |
Operating CF per Share |
(2.79) | (2.95) | (1.37) | (0.99) | |
Capex per Share |
(10.89) | 0.00 | 0.00 | (4.46) | |
Capex to Sales |
189.21 | 0.00 | 0.00 | 45.12 |
Columns are period end dates